BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38705206)

  • 1. "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
    Tondi L; Pica S; Crimi G; Disabato G; Figliozzi S; Camporeale A; Bernardini A; Tassetti L; Milani V; Piepoli MF; Lombardi M
    Int J Cardiol; 2024 Aug; 408():132135. PubMed ID: 38705206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy.
    Yang F; Wang L; Wang J; Pu L; Xu Y; Li W; Wan K; Yang D; Sun J; Han Y; Zhu Y; Chen Y
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):36. PubMed ID: 33761947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking: a feasibility study.
    Kowallick JT; Kutty S; Edelmann F; Chiribiri A; Villa A; Steinmetz M; Sohns JM; Staab W; Bettencourt N; Unterberg-Buchwald C; Hasenfuß G; Lotz J; Schuster A
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):60. PubMed ID: 25196447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
    Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
    Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study.
    Zhou D; Yang W; Yang Y; Yin G; Li S; Zhuang B; Xu J; He J; Wu W; Jiang Y; Sun X; Wang Y; Sirajuddin A; Zhao S; Lu M
    BMC Cardiovasc Disord; 2022 Mar; 22(1):99. PubMed ID: 35282817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a rapid semi-automated method to assess left atrial longitudinal phasic strains on cine cardiovascular magnetic resonance imaging.
    Leng S; Tan RS; Zhao X; Allen JC; Koh AS; Zhong L
    J Cardiovasc Magn Reson; 2018 Nov; 20(1):71. PubMed ID: 30396356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Heart Failure With Preserved Left Ventricular Ejection Fraction and Impaired Left Atrial Phasic Function in Hypertrophic Cardiomyopathy: Evaluation by Cardiac MRI Feature Tracking.
    Shi R; Shi K; Huang S; Li X; Xia CC; Li Y; He S; Li ZL; He Y; Guo YK; Yang ZG
    J Magn Reson Imaging; 2022 Jul; 56(1):248-259. PubMed ID: 34799953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse remodeling of left atrium assessed by cardiovascular magnetic resonance feature tracking in hypertrophic obstructive cardiomyopathy after septal myectomy.
    Yang S; Chen X; Zhao K; Yu S; Dong W; Wang J; Yang K; Yang Q; Ma X; Dong Z; Liu L; Song Y; Lu M; Wang S; Zhao S
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):13. PubMed ID: 36775820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
    Hinojar R; Zamorano JL; Fernández-Méndez M; Esteban A; Plaza-Martin M; González-Gómez A; Carbonell A; Rincón LM; Nácher JJJ; Fernández-Golfín C
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1055-1065. PubMed ID: 30706353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis.
    Moroni A; Tondi L; Milani V; Pieroni M; Pieruzzi F; Bevilacqua F; Pasqualin G; Chow K; Pica S; Lombardi M; Camporeale A
    Int J Cardiol; 2023 Dec; 393():131357. PubMed ID: 37696360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study.
    Tian D; Zhang J; He Y; Xiong Z; Zhao M; Hu S; Song Q; Li Z
    BMC Cardiovasc Disord; 2023 Jan; 23(1):42. PubMed ID: 36690952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance myocardial feature tracking for the determination of left atrial strain in hypertensive left ventricular hypertrophy and hypertrophic cardiomyopathy.
    Yao B; Wu R; Chen BH; Wesemann LD; Xu JR; Zhou Y; Wu LM
    Clin Radiol; 2023 May; 78(5):e409-e416. PubMed ID: 36746719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
    J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.
    Maragiannis D; Alvarez PA; Ghosn MG; Chin K; Hinojosa JJ; Buergler JM; Shah DJ; Nagueh SF
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):121-129. PubMed ID: 28748418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
    Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW
    PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
    Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.